Photronics, Inc. — Q3 FY2023 Form 10-Q
Reporting period: Three and nine months ended July 30, 2023; comparisons are against the prior-year periods ended July 31, 2022, unless noted. Dollar figures are in millions except per-share data. Photronics manufactures photomasks used in semiconductor integrated circuits (ICs) and flat-panel displays (FPDs).
Financial performance
| Metric | Q3 FY2023 | Q3 FY2022 | YTD FY2023 | YTD FY2022 |
|---|---|---|---|---|
| Revenue | $224.2 | $219.9 | $664.6 | $614.3 |
| Gross profit / margin | $86.8 / 38.7% | $83.9 / 38.1% | $251.3 / 37.8% | $213.9 / 34.8% |
| Operating income | $65.3 | $63.7 | $188.3 | $151.3 |
| Net income | $48.3 | $49.2 | $136.5 | $124.0 |
| Net income attributable to Photronics shareholders | $27.0 | $31.2 | $80.9 | $81.7 |
| Diluted EPS | $0.44 | $0.51 | $1.31 | $1.34 |
Q3 revenue decreased 2.2% sequentially and increased 1.9% year over year. IC revenue rose 1.2% year over year, while FPD revenue rose 4.0%. For the first nine months, revenue increased 8.2% and operating income increased about 24%. Q3 gross margin improved 60 basis points year over year; YTD gross margin rose 3.0 percentage points.
Q3 results were affected by a $4.5 million foreign-currency transaction loss, versus a $3.9 million gain in the prior-year quarter. Interest income and other income increased to $3.8 million from $0.4 million, partly offsetting the currency impact. The effective tax rate was 25.0% for Q3 and 26.8% YTD. A larger share of consolidated income was attributable to noncontrolling interests, contributing to lower shareholder-attributable earnings despite higher operating income.
Cash flow, liquidity, and debt
- YTD operating cash flow was $195.6 million, essentially unchanged from $195.9 million.
- YTD capital expenditures were $78.8 million, versus $46.3 million. Free cash flow, a company-defined non-GAAP measure, was $116.8 million, down from $149.6 million.
- Cash and cash equivalents were $448.5 million at July 30, 2023, including $429.9 million held by foreign subsidiaries; short-term investments were $27.3 million.
- Total debt was $26.7 million, consisting of finance leases; the Xiamen project loans were repaid in Q2. Company-reported net cash, a non-GAAP measure, was $421.8 million. No borrowings were outstanding under the corporate credit agreement.
- Current assets were $772.2 million and current liabilities were $190.7 million. Management stated liquidity was sufficient for the next 12 months and the foreseeable future.
Business trends, outlook, and risks
- Q3 IC revenue declined sequentially, primarily due to weaker mainstream demand in Asia. Year-over-year and YTD IC growth was led by mainstream products; high-end IC revenue declined 14.0% year over year in Q3.
- FPD revenue declined sequentially as softer high-end G10.5+ and LTPS demand outweighed continued AMOLED strength. Management said it expected strong AMOLED photomask demand to continue as technology advances support higher-value masks.
- Management estimated FY2023 capital expenditures of approximately $130 million, targeting IC capacity and efficiency. At quarter-end, capital commitments were about $118 million, with an additional $23.5 million in recognized equipment-purchase liabilities; the company estimated funding $120.3 million of combined commitments and recognized obligations over the next 12 months.
- The filing refers investors to the Q3 earnings release, presentation, and conference call for current business guidance; it does not provide specific guidance figures in the 10-Q text.
- Key risks include cyclical and volatile semiconductor and display design activity, pricing and capacity pressures, supply-chain disruption, and currency movements. A 10% adverse currency move was estimated to create a $51 million unrealized pretax loss at July 30, 2023; the largest stated exposures were the New Taiwan dollar, Korean won, and RMB.
- Photronics consolidates the PDMCX China joint venture and holds 50.01%; DNP has certain rights to put its interest to Photronics under specified circumstances. DNP had not indicated intent to exercise those rights. The company also disclosed a customs audit in China settled in November 2022, when it reversed $1.0 million of a previously recorded $2.2 million accrual; it said other ordinary-course claims were not expected to be material.
- Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter. No material changes to the risk factors in the 2022 Form 10-K were reported.
Important facts for investors to verify
- Whether subsequent results confirm the reported growth in mainstream IC demand and expected continued strength in AMOLED masks, given softer high-end IC and selected FPD demand.
- How planned capital spending and the $141.5 million of combined capital commitments and recognized obligations affect cash generation and free cash flow.
- The impact of currency exposure on earnings and cash, particularly given the quarter’s currency loss and the disclosed $51 million sensitivity estimate.
- The effect of noncontrolling interests on earnings attributable to Photronics shareholders, and the terms and potential implications of DNP’s PDMCX rights.
- Specific forward guidance and subsequent developments, which the filing directs readers to the separate Q3 earnings materials for.